Diagnostic model for pancreatic cancer using a multi-biomarker panel

PURPOSE: Diagnostic biomarkers of pancreatic ductal adenocarcinoma (PDAC) have been used for early detection to reduce its dismal survival rate. However, clinically feasible biomarkers are still rare. Therefore, in this study, we developed an automated multi-marker enzyme-linked immunosorbent assay...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yoo Jin, Yoon, Woongchang, Lee, Areum, Han, Youngmin, Byun, Yoonhyeong, Kang, Jae Seung, Kim, Hongbeom, Kwon, Wooil, Suh, Young-Ah, Kim, Yongkang, Lee, Seungyeoun, Namkung, Junghyun, Han, Sangjo, Choi, Yonghwan, Heo, Jin Seok, Park, Joon Oh, Park, Joo Kyung, Kim, Song Cheol, Kang, Chang Moo, Lee, Woo Jin, Park, Taesung, Jang, Jin-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943279/
https://www.ncbi.nlm.nih.gov/pubmed/33748028
http://dx.doi.org/10.4174/astr.2021.100.3.144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943279/
https://www.ncbi.nlm.nih.gov/pubmed/33748028
http://dx.doi.org/10.4174/astr.2021.100.3.144

Ejemplares similares